Biblio Discovery — Demo Discovery Service

18 hasil untuk "A. Hubner"

Menampilkan 1–18 · 0,36 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations

    Richard A. Hubner; Richard D. Riley; Lucinda J. Billingham dkk.

    PLoS ONE, Vol. 6 No. 10 · 2011 · Inggris · PLOS Scopus

    Purpose: Despite discrepant results on clinical utility, several trials are already prospectively randomizing non-small cell lung cancer (NSCLC) patients by ERCC1 status. We aimed to characterize the prognostic and predictive effect of ERCC1 by systematic review and meta-analysis. Methods: Eligible…

    Juga tersedia di: DOAJ

  2. Artikel Jurnal

    Comparison of an image cytometry somatic cell count analyzer to a flow cytometry analyzer

    A. Hubner; N. Taechachokevivat; J.M. Grantz dkk.

    JDS Communications, Vol. 4 No. 6 · 2023 · Inggris · DOAJ Scopus

    The objective of this study was to evaluate the performance of a small footprint benchtop somatic cell counter based on image cytometry (LactiCyte HD; Page and Pedersen International Ltd., Hopkinton, MA) against a flow cytometer employed at a regional dairy herd improvement (DHI) laboratory. Milk…

  3. Artikel Jurnal

    Future therapeutic strategies in the treatment of extrapulmonary neuroendocrine carcinoma: a review

    Matthew D. Robinson; Daniel Livesey; Richard A. Hubner dkk.

    Therapeutic Advances in Medical Oncology, Vol. 15 · 2023 · Inggris · DOAJ Scopus

    Neuroendocrine neoplasms (NENs) are rare malignancies arising most commonly in the gastrointestinal and bronchopulmonary systems. Neuroendocrine carcinomas (NECs) are a subgroup of NENs characterised by aggressive tumour biology, poor differentiation and dismal prognosis. Most NEC primary lesions…

  4. Artikel Jurnal Teks lengkap

    Systemic Therapy for Metastatic Pancreatic Cancer—Current Landscape and Future Directions

    Daniel Netto; Melissa Frizziero; Victoria Foy dkk.

    Current Oncology, Vol. 31 No. 9 · 2024 · Inggris · DOAJ Scopus

    Pancreatic ductal adenocarcinoma (PDAC) is a significant cause of cancer-associated mortality, with a rising global incidence. A paucity of strong predictive risk factors mean screening programmes are difficult to implement. Historically, a lack of identifiable and actionable driver mutations…

  5. Artikel Jurnal

    A randomized, controlled trial examining quarter-level somatic cell count and culture-based selective dry cow therapy against blanket dry cow therapy on early lactation production outcomes

    K. D'Amico; R.C. Neves; J.M. Grantz dkk.

    Journal of Dairy Science, Vol. 107 No. 9 · 2024 · Inggris · DOAJ Scopus

    ABSTRACT: The objective of this study was to determine quarters requiring antimicrobial treatment using either a benchtop somatic cell counter or culture with gram-positive selective media and compare the outcomes in these cows to those receiving blanket dry cow therapy (BDCT) in a randomized…

  6. Artikel Jurnal Teks lengkap

    Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular Carcinoma

    Victoria Foy; Mairéad G. McNamara; Juan W. Valle dkk.

    Current Oncology, Vol. 30 No. 9 · 2023 · Inggris · DOAJ Scopus

    The treatment of advanced unresectable HCC (aHCC) remains a clinical challenge, with limited therapeutic options and poor prognosis. The results of IMbrave150 and HIMALAYA have changed the treatment paradigm for HCC and established immune checkpoint inhibition (ICI), either combined with…

  7. Artikel Jurnal

    Second-line treatment in patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma: a systematic review and meta-analysis

    Mairéad G. McNamara; Melissa Frizziero; Timothy Jacobs dkk.

    Therapeutic Advances in Medical Oncology, Vol. 12 · 2020 · Inggris · DOAJ Scopus

    Background: There is no standard second-line treatment for patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma (EP-PD-NEC). This study explored data evaluating second-line treatment in these patients. Methods: A search of MEDLINE and EMBASE identified studies…

  8. Artikel Jurnal

    Characterization of metabolic profile, health, milk production, and reproductive outcomes of dairy cows diagnosed with concurrent hyperketonemia and hypoglycemia

    A. Hubner; I.F. Canisso; P.M. Peixoto dkk.

    Journal of Dairy Science, Vol. 105 No. 11 · 2022 · Inggris · DOAJ Scopus

    ABSTRACT: The objective of this prospective cohort study was to characterize the metabolic profile, health, milk production, and reproductive outcomes of cows diagnosed with hyperketonemia (HK; β-hydroxybutyrate ≥1.2 mmol/L), hypoglycemia (HG; glucose ≤2.2 mmol/L), or concurrent HK and HG (HKHG)…

  9. Artikel Jurnal

    Advanced extrahepatic cholangiocarcinoma and gallbladder cancer: Post-hoc analysis of the ABC-01, -02 and -03 clinical trials

    Angela Lamarca; Paul Ross; Harpreet S. Wasan dkk.

    JHEP Reports, Vol. 8 No. 7 · 2026 · Inggris · DOAJ Scopus

    Background & Aims: Previous data suggest that patients with intrahepatic cholangiocarcinoma (iCCA) have a better prognosis compared with those with other biliary tract cancers (BTC). However, granularity on outcomes for advanced extrahepatic cholangiocarcinoma (eCCA) (including distal- [dCCA] and…

  10. Artikel Jurnal Teks lengkap

    The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers

    Angela Lamarca; Salvatore Galdy; Jorge Barriuso dkk.

    PLOS ONE, Vol. 13 No. 10 · 2018 · Inggris · PLOS Scopus

    Introduction: Expression of human epidermal growth factor receptor (HER)2 and HER3 have been investigated in small BTC studies using variable scoring systems. Methods: HER2 and HER3 overexpression/amplification were explored following internationally agreed guidelines using immunohistochemistry…

    Juga tersedia di: DOAJ

  11. Artikel Jurnal

    Prospective observational study of prevalence, assessment and treatment of pancreatic exocrine insufficiency in patients with inoperable pancreatic malignancy (PANcreatic cancer Dietary Assessment (PanDA): a study protocol

    Angela Lamarca; Richard A Hubner; Zainul Abedin Kapacee dkk.

    BMJ Open, Vol. 11 No. 5 · 2021 · Inggris · DOAJ Scopus

    Introduction Pancreatic exocrine insufficiency (PEI) in patients with pancreatic malignancy is well documented in the literature and is known to negatively impact on overall survival and quality of life. A lack of consensus opinion remains on the optimal diagnostic test that can be adapted for use…

  12. Artikel Jurnal Teks lengkap

    NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

    Zev A. Wainberg; Davide Melisi; Teresa Mercade Macarulla dkk.

    The Lancet · 2023 · Inggris · OpenAlex

    Background Pancreatic ductal adenocarcinoma remains one of the most lethal malignancies, with few treatment options. NAPOLI 3 aimed to compare the efficacy and safety of NALIRIFOX versus nab-paclitaxel and gemcitabine as first-line therapy for metastatic pancreatic ductal adenocarcinoma (mPDAC)…

  13. Artikel Jurnal

    EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer

    Angela Lamarca; Annett Maderer; Daniel C. Wagner dkk.

    Translational Oncology, Vol. 72 · 2026 · Inggris · DOAJ Scopus

    Introduction: Immunotherapy recently approved with first-line (1L) chemotherapy for advanced biliary tract cancer (aBTC). Translational research is warranted to identify biomarkers for efficacy. Methods: This prospective multicenter non-randomised phase-II study recruited 50 treatment-naïve proven…

  14. Artikel Jurnal

    A Theory Informed Multi-Component Intervention to Promote Family Medicine Provider PrEP Prescription to Adolescent Girls and Young Women in the U.S. Southeast: Pilot Trial Results

    Lynn T. Matthews; Madeline C. Pratt; Oluwaseyi O. Isehunwa dkk.

    Journal of Primary Care & Community Health, Vol. 16 · 2025 · Inggris · DOAJ Scopus

    Background: Adolescent girls and young women (AGYW) in the U.S. Southeast are disproportionately affected by HIV. We developed and piloted PrEP-Pro, an intervention to support family medicine residents to prescribe HIV pre-exposure prophylaxis (PrEP), with a focus on AGYW. We pilot-tested the…

  15. Artikel Jurnal

    NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinomaResearch in context

    Mairéad G. McNamara; Jayne Swain; Zoe Craig dkk.

    EClinicalMedicine, Vol. 60 · 2023 · Inggris · DOAJ Scopus

    Summary: Background: The prognosis for patients with poorly-differentiated extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC) is poor. A recognised first-line (1L) treatment for advanced disease is etoposide/platinum-based chemotherapy with no standard second-line (2L) treatment. Methods…